Revvity Inc.
Diagnostics & Research
Healthcare
RVTY
120 M shares
NYSE US
traded
23 Sep 2025
listed
no
open
87.00
52 week high
127.67
high
87.76
52 week low
0.00
low
84.98
growth
-30.21 %
previous Close
86.27
P/E ratio
85
market cap
11.67 B
div yield
0
usd
Mar 2025
qoq
revenue
665 M
-8.86 %
net incoming
42.24 M
-55.37 %
eps
1.01 %
-28.87 %
eps surprise
6.32 %
net profit margin
6.35 %
-6.00 %
operating incoming
72.23 M
-39.17 %
net change in cash
-25.77 M
61.17 %
cash on hand
1.14 B
-2.22 %
cost of revenue
289 M
-8.79 %
top top